Close this search box.

The Voice of the

Commonwealth's Counties

Virginia Opioid Abatement Information


OAA information |

General questions can be sent to

Presentation slide decks are available at

OAA listserv – The Opioid Abatement Authority is developing a listserv. More information will be shared soon.

Videos of OAA information sessions for local government
All OAA sessions partnered with Virginia Institute of Government are available at the Weldon Cooper Center for Public Service’s YouTube channel –

February 1, 2023 grants process session

December 13, 2022 introductory session –

December 8, 2022 introductory session –

Upcoming OAA Q&A sessions
If you have not yet signed up for the March 8 and/or April 19 Question and Answer sessions, please register here:

Listening Sessions
The Opioid Abatement Authority and Virginia Association of Community Services Boards (VACSB) are holding public listening sessions across the Commonwealth.

Dates include

  • February 12, virtual
  • February 28, Norfolk
  • March 21, Region Ten CSB, Charlottesville
  • April 8, Southwest Virginia Higher Education Center, Abingdon

Register here:

Questions regarding the listening sessions should be directed to the Virginia Association of Community Services Boards (VACSB, or the Opioid Abatement Authority

Auditor of Public Accounts Locality Financial Reporting Guidance on Opioid Settlement Funds – December 2022

Summary of Key Provisions on the Use of Funds Received from National Opioid Settlements – Office of the Attorney General (November 30, 2022)

SAMHSA Opportunities below:

  • Grants to Expand Substance Use Disorder Treatment Capacity in Adult and Family Treatment Drug Courts (SAMHSA Treatment Drug Courts) – $32.4 million – This expands SUD treatment and recovery support services in existing drug courts. The program recognizes the need for treatment instead of incarceration for certain individuals who have SUDs.
  • Adult Reentry Program – $13 million – This program expands SUD treatment and related recovery and reentry services to adults in the criminal justice system who have an SUD and/or co-occurring substance use and mental disorders, who are returning to their families and communities after being incarcerated in state and local facilities including prisons, jails or detention centers.
  • Medication-Assisted Treatment – Prescription Drug and Opioid Addiction Grant Program (MAT-PDOA) – $18.2 million – This program provides resources to help expand or enhance access to medications for opioid use disorder (MOUD). This program will help to increase the number of people who receive MOUD for their opioid use disorders and decrease illicit opioid use and prescription opioid misuse.
  • Emergency Department Alternatives to Opioids Program (ED-ALT) – $6.8 million – This program develops and implements alternatives to opioids for pain management in hospitals and emergency department settings.
  • Sober Truth on Preventing Underage Drinking Act (STOP Act) Grants – $3 million – This program works to prevent and reduce alcohol use among youth and young adults ages 12-20 in communities throughout the United States. The program addresses norms regarding alcohol use by youth, reduces opportunities for underage drinking, creates changes in underage drinking enforcement efforts, addresses penalties for underage use, and reduces negative consequences associated with underage drinking (e.g., motor vehicle crashes, sexual assaults).
  • Grants for the Benefit of Homeless Individuals $15.7 million – The purpose of this program is to provide comprehensive, coordinated, and evidence-based treatment and services for individuals, including youth, and families with substance use disorders (SUDs) or co-occurring mental health conditions and SUDs (CODs) who are experiencing homelessness.
  • Improving Access to Overdose Treatment $1.4 million – The purpose of this program is to expand access to naloxone and other Food and Drug Administration (FDA) approved overdose reversal medications for emergency treatment of known or suspected opioid overdose. The recipients will collaborate with other prescribers at the community level to implement trainings on policies, procedures, and models of care for prescribing, co-prescribing, and expanding access to naloxone and other FDA-approved overdose reversal medications to the specified population of focus (i.e., rural or urban).

Briefing on Opioid Abatement Authority

Tony McDowell, Executive Director of the Opioid Abatement Authority, provided a briefing for VACo members on the Authority’s plans for the distribution of funding being provided to the state from recent settlements of opioid-related litigation. A portion of these funds will be provided to localities, in addition to the direct distributions localities are receiving from the settlements.

Link to Video

PowerPoint Presentation

VACo Contacts: Katie Boyle and Phyllis Errico, Esq., CAE

Monday, October 25, 2021 Webinar


PowerPoint Presentation

Resolution – MOU

Resolution – Distributors/JanssenSettlements


  • Sam Towell, Deputy Attorney General for Civil Litigation
  • Richard Schweiker, Jr., Senior Assistant Attorney General and Chief of the Consumer Protection Section
  • Tom Beshere, Assistant Attorney General
  • Delegate Terry Kilgore
  • Tim Spencer, City Attorney for the City of Roanoke and Board Member of the Virginia Opioid Abatement Authority
  • Leo Rogers, County Attorney for the County of Loudoun
  • Ed Spivey, Member of Kaufman & Canoles, Norfolk, Virginia
  • Burton LeBlanc, Shareholder of Baron & Budd, Dallas, Texas